NEXIUM LEVEL PROTECTION Trademark

Trademark Overview

On Monday, May 5, 2014, a trademark application was filed for NEXIUM LEVEL PROTECTION with the United States Patent and Trademark Office. The USPTO has given the NEXIUM LEVEL PROTECTION trademark a serial number of 86271219. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 3, 2021. This trademark is owned by AstraZeneca AB. The NEXIUM LEVEL PROTECTION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of gastrointestinal diseases
nexium level protection

General Information

Serial Number86271219
Word MarkNEXIUM LEVEL PROTECTION
Filing DateMonday, May 5, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 3, 2021
Registration Number4749423
Registration DateTuesday, June 2, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of gastrointestinal diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 3, 2021
Primary Code005
First Use Anywhere DateMonday, December 1, 2014
First Use In Commerce DateMonday, December 1, 2014

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, December 3, 2021CANCELLED SEC. 8 (6-YR)
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 2, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 2, 2015REGISTERED-PRINCIPAL REGISTER
Friday, May 1, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, April 30, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 30, 2015STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 26, 2015USE AMENDMENT FILED
Wednesday, April 29, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 26, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, December 2, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 7, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 2, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 29, 2014ASSIGNED TO LIE
Wednesday, August 20, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 20, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, August 20, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 20, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, August 20, 2014EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 19, 2014ASSIGNED TO EXAMINER
Friday, May 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 8, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

protection level nexium diseases gastrointestinal treatment preparations pharmaceutical